Intellia Therapeutics Inc NTLA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
53.40quote price arrow down-0.01 (-0.02%)
Volume
634,860
Close
53.41quote price arrow up+2.65 (+5.22%)
Volume
3,145,382
52 week range
37.08 - 202.73
Loading...
  • Open52.51
  • Day High55.23
  • Day Low49.30
  • Prev Close50.76
  • 52 Week High202.73
  • 52 Week High Date06/30/21
  • 52 Week Low37.08
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap4.051B
  • Shares Out75.85M
  • 10 Day Average Volume1.63M
  • Dividend-
  • Dividend Yield-
  • Beta2.00
  • YTD % Change-54.83

KEY STATS

  • Open52.51
  • Day High55.23
  • Day Low49.30
  • Prev Close50.76
  • 52 Week High202.73
  • 52 Week High Date06/30/21
  • 52 Week Low37.08
  • 52 Week Low Date06/14/22
  • Market Cap4.051B
  • Shares Out75.85M
  • 10 Day Average Volume1.63M
  • Dividend-
  • Dividend Yield-
  • Beta2.00
  • YTD % Change-54.83

RATIOS/PROFITABILITY

  • EPS (TTM)-5.04
  • P/E (TTM)-10.60
  • Fwd P/E (NTM)-9.95
  • EBITDA (TTM)-358.608M
  • ROE (TTM)-49.15%
  • Revenue (TTM)37.86M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-973.48%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Intellia Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Intellia Therapeutics, Inc. is a clinical-stage genome editing company. The Company is focused on developing curative therapeutics using Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) technology. CRISPR/Cas9 is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). It is focused on leveraging its modular platform to advance in vivo and ex vivo therapies for diseases with...
Frank Verwiel M.D.
Independent Chairman of the Board
John Leonard M.D.
President, Chief Executive Officer, Director
Glenn Goddard
Chief Financial Officer, Executive Vice President, Treasurer
David Lebwohl M.D.
Executive Vice President, Chief Medical Officer
Derek Hicks
Executive Vice President, chief business officer
Address
40 Erie St Ste 130
Cambridge, MA
02139-4254
United States

Top Peers

SYMBOLLASTCHG%CHG
KRTX
Karuna Therapeutics Inc
116.93+1.91+1.66%
CYTK
Cytokinetics Inc
47.25-0.22-0.46%
CERE
Cerevel Therapeutics Holdings Inc
28.15-0.48-1.68%
DNLI
Denali Therapeutics Inc
30.93+0.74+2.45%
TPTX
Turning Point Therapeutics Inc
75.17+0.02+0.03%